VIDAZA (azacitidine for injection) contains azacitidine, which is a pyrimidine nucleoside analog of cytidine.
VIDAZA (AZACITIDINE) INDICATIONS:
on May 19, 2004 the U.S. Food and Drug Administration (FDA) approved for treatment of myelodysplastic syndrome.
DOSAGE FORM & STRENGTH:
Vidaza (Azacitidine) 100mg distributor
Rasso swiss pharma is a Vidaza (Azacitidine) distributor, wholesaler, supplier. In addition to Vidaza Rasso Swiss Pharma can supply generic version of Azacitidine at much lower prices.